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Abstract: 
Background: Reliable diagnostic measures for the evaluation of  left ventricular systolic performance in the setting of  altered 
myocardial loading characteristics in sickle cell anaemia remains unresolved.
Objective: The study was designed to assess left ventricular systolic function in adult sickle cell patients using non-invasive end-
systolic stress – end-systolic volume index ratio.
Methods: A descriptive cross sectional comparative study was done using 52 patients recruited at the adult sickle cell anaemia 
clinic of  the University of  Nigeria Teaching Hospital Enugu. An equal number of  age and sex-matched healthy volunteers 
served as controls. All the participants had haematocrit estimation, haemoglobin electrophoresis, as well as echocardiographic 
evaluation.
Result: The mean age of  the patients and controls were 23.93 ± 5.28 (range 18-42)    and 24.17 ± 4.39 (range 19 -42) years re-
spectively, (t = 0.262; p= .794). No significant difference was seen in estimate of  fractional shortening, and ejection fraction. The 
cardiac out-put, cardiac index and velocity of  circumferential shortening were all significantly increased in the cases compared 
with the controls.  The end systolic stress – end systolic volume index ratio (ESS/ESVI) was significantly lower in cases than 
controls. There were strong positive correlation between the ejection phase indices (ejection fraction and fractional shortening) 
and end systolic stress and ESS/ESVI.
Conclusion: The study findings suggest the presence of  left ventricular systolic dysfunction in adult sickle cell anaemia. This is 
best detected using the loading-pressures independent force-length relationship expressed in ESS/ESVI ratio. 
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Introduction
Ejection phase indices have been used commonly as mea-
sures of  left ventricular systolic function1,2. These mea-
sures are highly dependent on and influenced by myo-
cardial loading conditions as well as heart rate, both of  
which are abnormal in sickle cell anaemia3,4. Use of  these 
indices of  systolic function in this population may ex-
plain the broad spectrum of  results and apparent incon-
sistencies documented in the literature5,6,7,8,9.
A number of  studies have examined the use of  the end 
systolic force-length relationship to characterize myocar-
dial contractility10,11,12. This relationship can be plotted us-
ing LV end-systolic pressure or wall stress as the force 
measurement and end-systolic LV volume, circumference 
or diameter as the length measurement. When force is 
expressed as wall stress, the myocardial after-load and 
contractile state can be readily compared in ventricles of  
different sizes and wall thicknesses, because these vari-
ables are included in the stress calculation. These indices 
of  myocardial performance which are independent of  
loading conditions have been shown to be more sensitive 
in the evaluation of  left ventricular systolic function in 
sickle cell anaemia4,10.
 
Although sickle cell anaemia is the commonest haemo-
globinopathy in sub-Saharan Africa, and is associated 
with increased cardiac morbidity, descriptive data on end 
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systolic stress in normal and abnormal left ventricles are 
limited13. Therefore, the present study was designed to 
provide an assessment of  left ventricular systolic function 
in adult sickle cell patients using non-invasive end-systolic 
stress-end systolic volume index ratio and to compare this 




From February 2004 to July 2005, a descriptive cross 
sectional case-control study was done using 52 cases re-
cruited at the adult sickle cell anaemia clinic of  the Uni-
versity of  Nigeria Teaching Hospital Enugu, Nigeria. The 
inclusion criteria for the cases included; haemoglobin 
genotype SS on haemoglobin electrophoresis, age > 18 
years, absence of  any form of  crises in the preceding four 
weeks informed consent to participate in the study, and 
clinic visit within the 18 months period of  study. All the 
cases who met the inclusion criteria were recruited.
An equal number of  age and sex matched healthy vol-
unteers served as controls. The eligibility criteria for the 
controls were: HbAA genotype, absence of  congenital or 
acquired heart disease, consent to participate in the study, 
absence of  pregnancy and/or inter-current illness, hae-
matocrit level greater than 30%. All the participants had 
haematocrit estimation, haemoglobin electrophoresis, as 
well as echocardiographic evaluation using Hewlett Pack-
ard Sonos2000 echocardiography machine with 3.7 MHz 
transducer. Systemic blood pressure was measured with 
an Accoson Mercury sphygmomanometer on the right 
arm, with the subjects in sitting positions, and the average 
of  3 readings used. The following measurements were 
taken in the standard positions as recommended by the 
American Society of  Echocardiography14,15. Aortic root 
diameter (Ao), left atrial dimension (LAD), left ventricu-
lar end diastolic diameter (LVEDD), left ventricular end 
systolic diameter (LVESD), right ventricular dimensions 
(RVD), septal wall thickness (SWT), posterior wall thick-
ness (PWT) were measured with M-mode. Fractional 
shortening (FS) (determined by EDD-ESD/EDD), left 
ventricular mass (LVM) using the standard convention, 
and left ventricular mass index (LVMI) (derived by divid-
ing LVM by body surface area) were derived from the 
M-mode measurements. End diastolic volume, and end 
systolic volume using the modified Simpson’s method, 
stroke volume, end systolic volume index (ESVI)(derived 
by dividing end systolic volume by body surface area), 
cardiac output, cardiac index, ejection fraction, were de-
rived from 2-dimensional B-mode imaging. Anterior mi-
tral valve E-point to septal separation (ES) and EF slope 
were also measured.
Left Ventricular wall stress (Left ventricular end-systolic 
stress LVESS) was determined using the angiographi-
cally Validated method of  Grossman and co-workers; 
(0.334 PxLVID/PWT [1 + PWT/LVID]). The value is 
expressed in kdyn.cm-2, where P = the left ventricular sys-
tolic pressure, LVID = LV diameter in systole and PWT 
= LV posterior wall thickness in systole16. The mean 
arterial systolic blood pressure was used as the left ven-
tricular systolic pressure, while the mean arterial blood 
pressure was calculated with the formula MAP = DBP 
+ 1/3 PP17; where MAP=mean arterial blood pressure, 
DBP=diastolic blood pressure, and PP=pulse pressure.
The total systemic resistance index was calculated as the 
ratio of  mean arterial blood pressure and cardiac index7 
and is expressed as dynes.sec. cm-5.m2   
Data analysis
Data is presented as means ± standard deviation for con-
tinuous variables and as proportions for categorical vari-
ables. Comparison of  continuous variables between the 
sickle cell disease patients group and the control group 
were made with independent Student’s t-test. For discrete 
variables distribution between groups were compared 
with Chi- square test and Fishers exact test as appropri-
ate (where an expected cell is less than 5).  Multivariate 
Pearson’s correlation analysis was used to examine the 
relationship between measures of  systolic function and 
clinical and echocardiographic variables.  The relationship 
was subsequently evaluated by means of  scatter-plots and 
regression models. All statistical analyses were carried out 
using the Statistical Packages for Social Sciences (SPSS 
Inc. Chicago Illinois) software version 11.0 and EPi-Info 
version 3.4. Statistical tests with probability values less 
than 0.05 were considered statistically significant.
Results
The mean age of  the patients and controls were 23.93 ± 
5.28 (range 18-42)    and 24.17 ± 4.39 (range 19 -42) years 
respectively (Table 1). 
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Table 1:       Age, gender and anthropometric data 
  
PARAMETERS 
                       
         SCA 
        Mean (SD) 
           
   CONTROLS 
    Mean (SD) 
       T-TEST         P-VALUE 
Age (years)           23.93(5.28) 24.17(4.39)     -.262       .794 
Gender 
{frequency(%)}                 
                                            

















    
  
       
         0.365 
  
 
      
   0.546a 
 
Weight(kg)      
                            
   54.56(8.63)    65.44(10.06)       -5.989     .000* 
 
Height(m)          
                          
   1.65(0.13)   1.67(0.12)     -1.054   .294 
Body surface  







    23.11(2.84) 
  
       -6.461 
       
        .000* 
  
Key: *Statistically significant, a= Chi-square, SCA= sickle cell anaemia, SD= standard deviation. 
There were no statistically significant age and gender dif-
ferences in patients and controls. The haematocrit, pulse 
and blood pressure indices are summarized in table 2. 
Significant findings in the patients were higher pulse rate, 
lower diastolic blood pressure, lower mean arterial blood 
pressure and increased pulse pressure. The various indi-
ces of  left ventricular systolic function are compared in 
table 3. 
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Table 2: Pulse and Blood pressure indices 
  
PARAMETERS SCA MEAN (SD) 
CONTROLS   MEAN 
(SD) T-TEST P-VALUE 
Pulse rate 
(beat/min) 85.17 (13.51) 76.81(10.00) 3.95 < .001* 
Brachial systolic 
BP(mmHg) 121.65(17.85) 119.04(11.81) .884 0.379 
Brachial diastolic 
BP(mmHg) 70.20 (10.61) 77.19(8.18) 3.787 < .001* 
Brachial pulse 
pressure (mmHg) 51.44(14.63) 41.85 (10.67) 3.848 0.001* 
Mean brachial 
arterial BP(mmHg) 87.35(11.56) 91.14 (8.11) 1.946 < .054* 
 Haematocrit (%) 24.07 (3.10) 38.65 (1.97) 30.589 < .001* 
 
          Key: *Statistically significant, SCA=sickle cell anaemia, SD=standard deviation. 
 
 








MEAN   (SD) 
T-TEST P- VALUE 
Cardiac output (L/Min) 6.82 (2.48) 3.69 (1.05) 8.516 <.0001* 
Cardiac index 
(L/min/M2) 
4.36 (1.79) 2.11 (0.55) 8.835 < 0.001* 
Ejection fraction (%) 66.89 (7.96) 65.88 (8.61) .506 .614 
Fractional shortening 
(%) 
39.56(7.65) 38.89(5.71) .512 .610 
VCS (cm/sec) 1.18 (0.25) 1.07(0.25) 2.423 .017* 
AOVMAX (cm/sec) 137.67 (25.17) 115.42 (18.26) 5.162 <.0001* 
TSRI( kdyne.sec.cm-
5.m2) 
22.68 (8.02) 46.20 (12.92) 11.212 < .001* 
ESS  ( Kdyne. cm-2) 33.46 (17.31) 28.88 (9.94) 1.698  .093 
ESVI (ml/m2) 25.27 (8.94) 13.69 (4.01) 8.592 < .001* 
ESS/ESVI ratio 1.68 (0.23) 2.38 (0.18) 2.389 .019* 
LVMI (gm/m2) 132.01(40.02) 86.42 (19.02) 7.432 <.001* 
 Key:*statistically significant, ESS= left ventricular end systolic stress, ESVI= left ventricular end systolic 
volume index, LVMI= left ventricular mass index. AOVMAX = peak aortic systolic velocity, VCS= velocity 
of circumferential shortening, SCA=sickle cell anaemia, SD=standard deviation. 
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MEAN   (SD) 
T-TEST P- VALUE 
Cardiac output (L/Min) 6.82 (2.48) 3.69 (1.05) 8.516 <.0001* 
Cardiac index 
(L/min/M2) 
4.36 (1.79) 2.11 (0.55) 8.835 < 0.001* 
Ejection fraction (%) 66.89 (7.96) 65.88 (8.61) .506 .614 
Fractional shortening 
(%) 
39.56(7.65) 38.89(5.71) .512 .610 
VCS (cm/sec) 1.18 (0.25) 1.07(0.25) 2.4 3 0 7* 
AOVMAX (cm/sec) 137.67 (25.17) 115.42 (18.26) 5.162 <.0001* 
TSRI( kdyne.sec.cm-
5.m2) 
22.68 (8.02) 46.20 (12.92) 11.212 < .001* 
ESS  ( Kdyne. cm-2) 33.46 (17.31) 28.88 (9.94) 1.698  .093 
ESVI (ml/m2) 25.27 (8.9 ) .  ( . ) .  < .001* 
ES /ESVI ratio 1.68 (0.23) 2.38 (0.18) 2.389 .019* 
LVMI (gm/m2) 132.01(40.02) 86.42 (19.02) 7.432 <.001* 
 Key:*statistically significant, ESS= eft ventricular end systolic stress, ESVI= left ventricular end systol c 
volume index, LVMI= left ventricular mass index. AOVMAX = peak aortic systolic velocity, VCS= velocity 
of circumferential shortening, SCA=sickle cell anaemia, SD=standard deviation. 
No significant difference was seen in estimate of  frac-
tional shortening, and ejection fraction. The cardiac 
out-put, cardiac index and velocity of  circumferential 
shortening were all significantly increased in the patients 
compared with the controls.  The end systolic stress end 
systolic volume index ratio (ESS/ESVI) was significantly 
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lower in patients than controls; (1.68 ± 0.23 and 2.38 ± 
0.18 respectively, t= 2.389; p=.019). The total systemic 
resistance index was also significantly lower in the pa-
tients, (22.68 ± 8.02; 46.20±12.92, t=11.212, p= <.001). 
Multivariate correlation analysis revealed strong positive 
correlation between the ejection phase indices (ejection 
fraction and fractional shortening) and end systolic stress 
and ESS/ESVI (tables 4 and 5).  
Table 4: Multivariate correlation of clinical and echocardiographic variables in sickle cell anaemia. 
 




Correlation .119 -.086 .137 .126 .083 .017 .158 .076 .147 .633
** -.180 .366** -.161 .150 
Sig. (2-tailed) .390 .536 .324 .365 .550 .902 .255 .587 .288 .000 .196 .007 .248 .278 
Cardiac index Pearson 
Correlation -.098 .570
** .213 .173 -.281* -.333* -.070 .134 .215 -.039 .162 -.190 .489** -.820** 
Sig. (2-tailed) .481 .000 .122 .212 .040 .015 .615 .333 .118 .780 .248 .172 .000 .000 
Ejection fraction Pearson 
Correlation .136 .148 .057 -.160 -.224 -.304
* -.129 .186 -.069 .235 -.655** .505** .271 -.331* 
Sig. (2-tailed) .325 .287 .681 .247 .103 .027 .353 .177 .622 .087 .000 .000 .050 .014 
VCF Pearson 
Correlation .049 .280
* .161 .222 -.217 -.208 -.188 .035 .218 .315* -.054 .186 .171 -.006 
Sig. (2-tailed) .724 .040 .246 .107 .115 .135 .174 .800 .113 .020 .699 .182 .220 .963 
AoVmax Pearson 
Correlation -.185 .139 .215 .011 -.189 -.213 -.250 .254 .117 -.094 -.008 -.166 .239 -.155 
Sig. (2-tailed) .180 .316 .119 .936 .171 .125 .068 .064 .398 .499 .955 .234 .085 .265 
ESS Pearson 
Correlation .211 .052 .435
** .148 .130 .062 .093 .423** .314* 1 -.232 .669** -.005 .160 
Sig. (2-tailed) .126 .709 .001 .284 .350 .658 .502 .001 .021   .094 .000 .969 .249 
ESVI Pearson 
Correlation -.164 -.094 .078 .228 .232 .269 .158 -.071 .180 -.232 1 -.628
** .035 -.169 
Sig. (2-tailed) .242 .502 .580 .100 .095 .051 .259 .614 .198 .094   .000 .805 .227 
ESS/ESVI Pearson 
Correlation .384
** .085 .048 -.232 -.113 -.137 -.075 .227 -.117 .669** -.628**      1 -.097 .222 
Sig. (2-tailed) .005 .546 .732 .094 .422 .329 .592 .102 .403 .000 .000   .488 .109 
LVMI Pearson 
Correlation -.004 .298
* .314* .258 -.354** -.342* -.343* .195 .319* -.005 .035 -.097 1 -.283* 
Sig. (2-tailed) .978 .030 .022 .062 .009 .012 .012 .161 .020  .969 .805 .488   .040 
TSRI Pearson 
Correlation .102 -.487
** .095 .139 .169 .231 .015 .015 .134 .160 -.169 .222 -.283* 1 
Sig. (2-tailed) .464 .000 .493 .316 .221 .096 .916 .912 .333 .249 .227 .109 .040   
ESD Pearson 
Correlation -.190 .164 .006 .047 -.047 .025 -.108 -.027 .032 -.688** .388** -.646**  -.325* -.274* 
  Sig. (2-tailed) .168 .236 .967 .737 .736 .862 .436 .847 .820 .000 .004 .000 .018 .045 
 
         Key: **statistically significant <.01, *significant <.05, ESS= left ventricular end systolic stress, ESVI= left ventricular end systolic volume index, LVMI= left ventricular mass  
         index. AOVMAX = peak aortic systolic velocity, VCS= velocity of circumferential shortening, MAP=mean arterial pressure, SBP=systolic blood pressure, DBP=diastolic blood    
         pressure, BSA=body surface area. 
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Table 5: Relationship between ESS/ESVI and Ejection indices of systolic function;  
regression model summary. 
 
Relationship/Model 
Model Summary/ Parameter estimates 
R B Constant F Significance 
ESS/ESVI and FS in 
SCA 
          
     Linear .366 0.080 -1.485 7.907 .007* 
     Logarithm .360 2.994 -.9.273 7.605 .008* 
     Quadratic .368 0.030 -0.517 3.904 .027* 
ESS/ESVI and FS in 
Controls 
          
      Linear .546 0.124 -2.446 21.265 .000* 
      Logarithm .535 4.527 -14.140 20.034 .000* 
      Quadratic .555 -0.143  2.533 10.928 .000* 
ESS/ESVI and EF in 
SCA 
          
       Linear .505 0.108 -5.489 17.430 .000* 
       Logarithm .487 6.993 -27.620 15.879 .000* 
       Quadratic .557 -0.581 17.645 11.237 .000* 
ESS/ESVI and EF in 
Controls 
          
        Linear .018 -0.020 30.223 0.017 .897 
        Quadratic .505 -0.390 12.231 8.587 .001* 
        Cubic .510 -0.180 8.264 8.619 .001* 
 
This relationship was further evaluated by means of  scat-
ter plots and subsequently by regression analysis. The 
suitability of  various regression models for explanation 
of  variations in the dependable variables were examined 
using ANOVA, while the strength of  the relationship was 
determined by the parameter estimates and model sum-
mary report (table 6). The relevant regression models are 
summarized in table 5 and the actual plots presented in 
figures 1-4. Regular linear models seem to explain the re-
lationship between ESS/ESVI and ejection phase indices 
in sickle cell anaemia patients (Figures 1 and 3). The rela-
tionship in the controls were less predictable and irregular 
(table 5, Figures 2 and 4).
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Discussion
The evaluation of  left ventricular systolic function in 
sickle cell anaemia has yielded inconsistent results, proba-
bly due to the differences in patient’s selection criteria and 
the indices of  systolic function employed in the studies. 
Ejection phase indices are commonly used as measures 
of  left ventricular systolic function. However, it has been 
observed that alterations in the loading characteristics of  
the heart in patients with chronic anaemia affect the ejec-
tion performance of  the heart4,5.
 
Using ejection phase indices as measures of  systolic func-
tion, this study did not demonstrate any significant dif-
ference in ejection fraction, fractional shortening and ve-
locity of  circumferential shortening between cases and 
controls. This is in keeping with findings from previous 
studies7,8.  Adebiyi et al7 found no significant difference in 
the left ventricular systolic function at rest between sickle 
cell patients and controls using ejection phase indices. 
The cases were aged 16years and above, but their mean 
age was not specified. Similarly, Covitz et al8 found nor-
mal left ventricular systolic function in stable sickle cell 
anaemia patients as indicated by normal fractional short-
ening, and systolic time intervals.
In contrast to the above findings, some researchers re-
ported abnormal left ventricular function in sickle cell 
patients. 
Left ventricular performance determined by echocar-
diography in 44 black children with sickle cell anaemia 
and a control group of  28 normal black children of  com-
parable age by Rees et al5 revealed statistically significant 
differences between the children with sickle cell anaemia 
and the normal group in left ventricular ejection fraction, 
cardiac index, mean circumferential fiber shortening ve-
locity, and the percentage of  shortening of  left ventricu-
lar minor axis dimension.  These findings consistent with 
left ventricular systolic function have been corroborated 
by the report of  Balfour and colleagues6 who also ob-
served that left ventricular function became increasingly 
abnormal with age, suggesting that left ventricular func-
tion deteriorated with time. It is worth noting that most 
of  the studies reporting abnormal systolic function in 
sickle cell patients were conducted in children whereas 
most of  adult studies reported normal systolic function. 
The conflicting results of  these studies have been attrib-
uted to  different selection factors in the study groups, an 
improvement in left ventricular function  with age  or  a 
high mortality among children with  abnormal left ven-
tricular function so that such patients do not appear in 
adult samples.
However, the validity of  using ejection phase indices as 
indicators of  left ventricular function under the altered 
loading condition in chronic anaemia has been chal-
lenged4. Using the end systolic stress-dimension relation-
ship as an index of  contractile function independent of  
loading pressures, this study demonstrated a statistically 
significant reduction in the end systolic stress-end systol-
ic dimension ratio index in sickle cell patients compared 
with controls. This finding is consistent with systolic dys-
function. End systolic wall stress (ESWS) is an impor-
tant determinant of  ventricular shortening, and reduction 
in wall stress facilitates ventricular emptying10. Ejection 
fraction is affected by changes in preload and afterload. 
End systolic volume is relatively independent of  preload 
and varies linearly with afterload11,12. A higher ESWS/
ESVI ratio would indicate relatively greater left ventricu-
lar shortening at a given after-load, and a lower ESWS/
ESVI would indicate less shortening for a given after-load 
and thus relatively poorer left ventricular function.
Adebiyi et al7, in a study in Ibadan, Nigeria on thirty sickle 
cell patients (aged > 16 years) using similar indices, ob-
served that the end systolic stress-end systolic dimension 
ratio although lower in sickle cell patients was not signifi-
cantly different from that of  the controls. This discrepan-
cy could be explained by the smaller sample size and the 
relatively younger patients in the latter study, especially in 
the light of  the findings by this study of  a negative cor-
relation between the pressure indices of  systolic function 
and age.
The unreliability of  ejection phase indices in the determi-
nation of  left ventricular function in patients with sickle 
cell anaemia is due to their inability to accurately quantify 
the relative contribution of  each of  the variables that af-
fect left ventricular pump function. These variables in-
clude; myocardial contractile state, end-diastolic myocar-
dial length, afterload and LV myocardial mass11. In sickle 
cell anaemia, preload is increased due to left ventricular 
hypertrophy and cardiac chamber enlargement second-
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ary to chronic anaemia and hyper-dynamic circulation18. 
The after-load is reduced due to decrease in peripheral 
resistance and increased heart rate. These changes tend 
to normalize ejection phase indices, even in the presence 
of  left ventricular dysfunction4. In our study, the role of  
the preload and after load variables appear to be quite 
remarkable in view of  the findings of  reduced total sys-
temic resistance index, higher heart rate, and elevated left 
ventricular mass and left ventricular dimensions. Regres-
sion plot of  the ESS/ESVI and ejection phase indices 
indicated strong linear relationship in sickle cell patients, 
a feature that was not evident in the controls. This obser-
vation indicates the discriminatory value of  the pressure 
indices of  systolic function in the evaluation of  patients 
with altered loading conditions as seen in sickle cell anae-
mia, rather than in the generality of  patients.
The ESS/ESVI ratio has been shown to be more sensitive 
than ejection fraction or other hemodynamic variables in 
predicting surgical outcome in symptomatic patients with 
chronic mitral regurgitation12.
In spite of  its accuracy in assessing systolic function, the 
use of  ESS/ESVI is challenged by some limitations. A 
major challenge to the application of  this measure is the 
lack of  data on the acceptable normal range and cut-off  
values for diagnosis of  left ventricular systolic dysfunc-
tion. Secondly, the ESS/ESVI is subject to a wide range 




The findings suggest the presence left ventricular sys-
tolic dysfunction in adult sickle cell anaemia. This is best 
detected using the loading-pressures independent force-
length relationship expressed in ESS/ESVI ratio. 
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